Correlation Between Neuropace and IRhythm Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and IRhythm Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and IRhythm Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and iRhythm Technologies, you can compare the effects of market volatilities on Neuropace and IRhythm Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of IRhythm Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and IRhythm Technologies.

Diversification Opportunities for Neuropace and IRhythm Technologies

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Neuropace and IRhythm is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and iRhythm Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iRhythm Technologies and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with IRhythm Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iRhythm Technologies has no effect on the direction of Neuropace i.e., Neuropace and IRhythm Technologies go up and down completely randomly.

Pair Corralation between Neuropace and IRhythm Technologies

Given the investment horizon of 90 days Neuropace is expected to generate 1.43 times more return on investment than IRhythm Technologies. However, Neuropace is 1.43 times more volatile than iRhythm Technologies. It trades about 0.01 of its potential returns per unit of risk. iRhythm Technologies is currently generating about 0.01 per unit of risk. If you would invest  1,661  in Neuropace on November 3, 2024 and sell it today you would lose (285.00) from holding Neuropace or give up 17.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  iRhythm Technologies

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
iRhythm Technologies 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in iRhythm Technologies are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, IRhythm Technologies exhibited solid returns over the last few months and may actually be approaching a breakup point.

Neuropace and IRhythm Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and IRhythm Technologies

The main advantage of trading using opposite Neuropace and IRhythm Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, IRhythm Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IRhythm Technologies will offset losses from the drop in IRhythm Technologies' long position.
The idea behind Neuropace and iRhythm Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format